everyday health magazine
With only one FDA-approved drug available for PPMS, this type of multiple sclerosis remains difficult to treat, but adaptive devices and wellness programs can help you manage your symptoms.

For many people with multiple sclerosis (MS), treatment is focused on preventing and managing relapses — acute symptoms that are often absent for long stretches of time. Ultimately the disease can result in disability in walking, thinking, and working.

But in people with primary-progressive MS (PPMS) — a small subset of the overall MS population — there is no initial relapse that heralds the onset of the disease, just a gradual appearance of symptoms. This can make PPMS more difficult to identify than so-called relapsing-remitting MS. To make matters more difficult, out of the 23 disease-modifying treatments currently available for MS in the United States, only one is approved for PPMS.

Despite the challenges that PPMS presents, great strides have been made in its treatment and management. Here are 10 things you should know about PPMS.


Disclaimer: Content on our site is provided for information purposes only; therefore, this material is not intended to advise. This information includes a link to a site that is maintained by another; MS Monterey is not responsible for content on this site. Please remember to consult with your doctor or health care provider before making any changes to your medication(s) or medical regimen.